Siamak Khavandi
1* 
, Elsa Tabibzadeh
2 , Saeed Shoar
3 , Mahdi Mohamadkhani
1 , Soheila Khavandi
4 1 Department of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran
2 Department of Anaesthesiology and Critical Care, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Clinical Research, ScientificWriting Corporation, Houston, Texas, USA
4 Department of Cardiology, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract
Coronavirus disease 2019 (COVID-19) is a viral respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since its first appearance in December 2019, COVID-19 has been responsible for a number of global outbreaks and has claimed the lives of nearly three million people as of April 2021. High infection rate, loss of taste and smell, fever, cough, and severely adverse effects on the respiratory system have been the chief attributes of the virus. However, SARS-CoV-2 has been linked to other symptoms, many of which are extra-pulmonary or not directly related to the respiratory system. The impact of SARS-CoV-2 on various ophthalmic outcomes has been manifested in many reports and literature tracing the link between COVID-19 and ocular findings in patients suffering from COVID-19. One recurrent case report presented in the literature is related to the presentation of conjunctivitis in COVID-19 patients. Conjunctivitis is a viral infection causing inflammation in conjunctiva, episclera and eyelids resulting in a change of color in eyes, called pink eyes. Swelling, itching, pain, and eye burn are some of the common symptoms. The present study reviews the latest literature on the subject by focusing on the reports of conjunctivitis symptoms in patients with COVID-19.